Showing results (1-10 of 410) with videos related to
Sort By:
Pageof 41
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Patterns of Response and Progression to ImmunotherapyEdith Borcoman, Amara Nandikolla, Georgina Long, et al.Therapeutic Advances in Medical Oncology|June 14, 2017
Pembrolizumab in cervical cancer: latest evidence and clinical usefulnessEdith Borcoman, Christophe Le TourneauCurrent Opinion in Oncology|July 2, 2016
Antibody drug conjugates: the future of chemotherapy?Edith Borcoman, Christophe Le TourneauInternational Journal of Molecular Sciences|June 2, 2019
Hyperprogression under ImmunotherapyMaxime Frelaut, Christophe Le Tourneau, Edith BorcomanExpert Opinion on Biological Therapy|July 20, 2019
Pembrolizumab for the treatment of cervical cancerGrégoire Marret, Edith Borcoman, Christophe Le TourneauCurrent Opinion in Oncology|July 2, 2019
Molecular screening programs in different countries: what we learned and perspectivesEdith Borcoman, Christophe Le Tourneau, Maud KamalCancers|June 2, 2021
Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaEdith Borcoman, Gregoire Marret, Christophe Le TourneauCurrent Opinion in Oncology|March 26, 2023
Window-of-opportunity clinical trials for biomarker discovery in head and neck squamous cell carcinomaGrégoire Marret, Edith Borcoman, Christophe Le TourneauBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 13, 2020
Pseudoprogression and Hyperprogression as New Forms of Response to ImmunotherapyMaxime Frelaut, Pauline du Rusquec, Alexandre de Moura, et al.Cancers|January 11, 2022
HDAC Inhibition to Prime Immune Checkpoint InhibitorsEdith Borcoman, Maud Kamal, Grégoire Marret, et al.Pageof 41